Literature DB >> 1433324

Lysophosphatidylcholine-induced Ca(2+)-overload in isolated cardiomyocytes and effect of cytoprotective drugs.

L Ver Donck1, G Verellen, H Geerts, M Borgers.   

Abstract

It has been previously demonstrated that lysophosphatides accumulate rapidly in ischaemic tissue, and may play a key role in the genesis of ischaemia-reperfusion injury. The present study investigated the effects of exogenously added lysophosphatidylcholine (1-20 microM) on single isolated cardiomyocytes from adult rabbit hearts. Quiescent cells exposed to > or = 8 microM lysophosphatidylcholine dose-dependently displayed irreversible hypercontraction, whereas after 60 min at 3 microM lysophosphatidylcholine, most cells remained rod-shaped (87.2 +/- 2.0%, mean +/- S.E.M.). However, when combined with electrical field stimulation (1 Hz), exposure to 3 microM lysophosphatidylcholine resulted in irreversible hypercontracture of most cells after 60 min: only 27.5 +/- 7.5% of the cells remained rod-shaped. Contracture depended upon the presence of extracellular Ca2+, and coincided with a significant rise in the median intracellular free Ca2+ level from 72.2 to 352.1 nM (P = 0.0001), suggesting intracellular Ca(2+)-overload. Pretreatment with 10(-6) M flunarizine or R 56865 significantly reduced the fraction of damaged cells when exposed to 3 microM lysophosphatidylcholine and electrical stimulation: 78.3 +/- 12.2% and 56.3 +/- 13.1% respectively of the cells remained rod-shaped. No protection was observed when quiescent cells were exposed to 10 microM lysophosphatidylcholine. Cytochemical localization of Ca2+ showed that lysophosphatidylcholine induced a loss of sarcolemma-bound Ca2+ precipitate and an accumulation of Ca2+ clusters in mitochondria of damaged cells in a dose and time dependent way. These results suggest that lysophosphatidylcholine induces functional and structural damage (Ca(2+)-overload) in isolated cardiomyocytes and that this can be prevented by cytoprotective drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433324     DOI: 10.1016/0022-2828(92)91864-2

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Cell membrane-derived lysophosphatidylcholine activates cardiac ryanodine receptor channels.

Authors:  Yuki Nakamura; Midori Yasukochi; Sei Kobayashi; Kiyoko Uehara; Akira Honda; Ryuji Inoue; Issei Imanaga; Akira Uehara
Journal:  Pflugers Arch       Date:  2006-10-07       Impact factor: 3.657

2.  Exogenous lysophosphatidylcholine increases non-selective cation current in guinea-pig ventricular myocytes.

Authors:  K Magishi; J Kimura; Y Kubo; Y Abiko
Journal:  Pflugers Arch       Date:  1996-06       Impact factor: 3.657

Review 3.  Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Authors:  Albertas Undrovinas; Victor A Maltsev
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10

4.  Early metabolic inhibition-induced intracellular sodium and calcium increase in rat cerebellar granule cells.

Authors:  W H Chen; K C Chu; S J Wu; J C Wu; H A Shui; M L Wu
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

5.  Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.

Authors:  M Chen; H Hashizume; Y Abiko
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  Baicalein, an active component of Scutellaria baicalensis Georgi, prevents lysophosphatidylcholine-induced cardiac injury by reducing reactive oxygen species production, calcium overload and apoptosis via MAPK pathways.

Authors:  Huai-Min Chen; Jong-Hau Hsu; Shu-Fen Liou; Tsan-Ju Chen; Li-Ying Chen; Chaw-Chi Chiu; Jwu-Lai Yeh
Journal:  BMC Complement Altern Med       Date:  2014-07-09       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.